3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Leukemia, Myeloid, Acute
3
Prostatic Neoplasms
2
Pancreatic Neoplasms
2
Neoplasms
2
Melanoma
2
Malignant Solid Neoplasm
2
Hematopoietic and Lymphatic System Neoplasm
2
Hematologic Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Renal Cell
2
COVID-19
2
Urologic Neoplasms
1
Urologic Diseases
1
Urinary Bladder Neoplasms
1
Ureteral Neoplasms
1
Teratoma
1
Stomatitis
1
Squamous Cell Carcinoma of Head and Neck
1
Spondylitis, Ankylosing
1
Renal Insufficiency, Chronic
1
Psoriasis
1
Precursor Cell Lymphoblastic Leukemia-Lymphoma
1
Peritoneal Neoplasms
1
Oropharyngeal Neoplasms
1
Neoplasms, Germ Cell and Embryonal
1
Neoplasm Metastasis
1
Nasopharyngeal Carcinoma
1
Myeloproliferative Disorders
1
Myelodysplastic Syndromes
1
Mouth Neoplasms
1
Interventions
Cyclophosphamide
15
Biopsy
15
Specimen Handling
13
Magnetic Resonance Spectroscopy
13
Rituximab
11
obinutuzumab
7
fludarabine
7
Lenalidomide
7
pembrolizumab
6
Prednisone
6
Vincristine
5
Doxorubicin
5
glofitamab
4
copanlisib
4
Nuclear Medicine Department, Hospital
4
trametinib
3
sapanisertib
3
fludarabine phosphate
3
X-Rays
3
Tacrolimus
3
Nivolumab
3
Mycophenolic Acid
3
GSK2636771
3
Etoposide
3
Crizotinib
3
Busulfan
3
Bendamustine Hydrochloride
3
zanubrutinib
2
venetoclax
2
ulixertinib
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Lymphoma
×
Practice Guidelines as Topic
×
30 days
×
Clear all
No trials found.